Drug Recall Enforcement Reports
What are the Drug Enforcement Reports?
All drug recalls are monitored by the Food and Drug Administration (FDA) and are included in the Enforcement Report once they are properly classified. The FDA will determine if a firm's removal or correction actions of a marked product meet the requirements to be considered a "recall". The FDA will also determine the public hazard assessment and a recall classification will be published in the Enforcement Report.
The Drug Enforcement Reports included in this listing was last updated on October 09, 2026 and include a total of 18002 recall reports.
| Recall Number | Recall Initiation Date | Product Description | Recall Reason | Recall Firm / Quantity | Recall Classification | Status |
|---|---|---|---|---|---|---|
| D-0880-2022 | 05-03-2022 | Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals), 100 mg, 100 Capsules (10 x 10), 10-count blisters per card, 10 cards per carton, Unit Dose NDC 68084-446-11, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC: 68084-446-01 | Failed Dissolution Specifications: Nitrofurantoin Capsules recalled due to dissolution failure at 0-time of the repackaged lot. Drug release results were above specification at 0-time. | American Health Packaging / 1603 cartons | Class III | Terminated |
| D-0881-2022 | 05-03-2022 | Sirolimus Oral Solution, 1 mg/mL, 60 mL bottle, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-6197-2 | Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the specification limit at the 14-month timepoint. | Apotex Corp. / 2353 bottles | Class III | Terminated |
| D-0855-2022 | 05-02-2022 | MVASI (bevacizumab-awwb), Injection, For Intravenous Infusion After Dilution, 100 mg/4 ml, Single dose vial, Rx only, Manufactured by Amgen Inc. Thousand Oaks, CA 91320-1799, NDC 55513-0206-01 | Defective container: loose crimp defect, potential loss of container integrity. | Amgen, Inc. / 15,823 | Class II | Terminated |
| D-0887-2022 | 05-02-2022 | Losartan HCTZ 100/12.5 mg, 90 count bottles NDC# 70518-2564-00 Repackaged NDC Original NDC # 68180-0216-09 | CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits. | RemedyRepack Inc. / 30 bottles/90 count = 2,700 tablets | Class II | Terminated |
| D-0886-2022 | 05-02-2022 | Losartan HCTZ 100/25 mg, 90 count bottles NDC# 70518-2578-00 Repackaged NDC Original NDC # 68180-0217-09 | CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits. | RemedyRepack Inc. / 26/90 count bottles = 2,340 tablets | Class II | Terminated |
| D-0890-2022 | 04-29-2022 | Higher Education Make Out Ready Vegan Lip Balm, SPF 15, Net Wt. 0.15 oz (4.25 g) per tube, Active Ingredients: Oxtinoxate (7.5%), Oxybenzone (3%); Distributed by: Higher Education Skincare, 1.833.251.0388 | Mislabeling: The active ingredient list on the label does not match the product's actual ingredients Specifically, the label states Octinoxate 7.5% and Oxybenzone 3%, while the product therein is made with Octinoxate 7.5%, Octisalate 5%, Octocrylene 5%, and Avobenzone 3%. | Eco Lips, Inc / 17,000 units | Class III | Terminated |
| D-0858-2022 | 04-29-2022 | buPROPion Hydrochloride Extended-Release Tablet, USP (SR), 200 mg, 60-count bottle, Rx only Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 47335-738-86 Package NDCs: 47335-736-86; 47335-736-88; 47335-736-08; 47335-736-13; 47335-737-86; 47335-737-88; 47335-737-08; 47335-737-13; 47335-738-86; 47335-738-88; 47335-738-08; 47335-738-13 | Presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the bottle which was determined to be activated carbon from the desiccant canister inside the bottle. | SUN PHARMACEUTICAL INDUSTRIES INC / 744 bottles | Class III | Terminated |
| D-0857-2022 | 04-29-2022 | buPROPion Hydrochloride Extended-Release Tablet, USP (SR), 150 mg packaged in a) 60-count bottle (47335-737-86), b)100-count bottle (47335-737-88), c)500-count bottle (47335-737-13), Rx only Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Halol-Baroda Highway, Halol-389 350, Gujarat, India Package NDCs: 47335-736-86; 47335-736-88; 47335-736-08; 47335-736-13; 47335-737-86; 47335-737-88; 47335-737-08; 47335-737-13; 47335-738-86; 47335-738-88; 47335-738-08; 47335-738-13 | Presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the bottle which was determined to be activated carbon from the desiccant canister inside the bottle. | SUN PHARMACEUTICAL INDUSTRIES INC / 9804 bottles | Class III | Terminated |
| D-0844-2022 | 04-28-2022 | alprazolam XR extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977, NDC 59762-0068-1. Package NDCs: 59762-0057-1; 59762-0059-1; 59762-0066-1; 59762-0068-1 | Failed Dissolution Specifications: low out-of-specification dissolution test results observed. | Viatris Inc / 6,789 bottles | Class II | Terminated |
| D-0854-2022 | 04-28-2022 | Xanax XR (alprazolam) extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Fizer Inc, NY, NY 10017, NDC 0009-0068-07. | Failed Dissolution Specifications: low out of specification results for dissolution. | Viatris Inc / 110 bottles | Class II | Terminated |
| D-0875-2022 | 04-27-2022 | GaviLyte -C (Polyethylene Glycol 3350, 240 g) and electrolytes for Oral Solution, USP with flavor pack NDC# 43386-060-19 Package NDCs: 43386-060-19 | Failed Stability Specification | Lupin Pharmaceuticals Inc. / 26,910 bottles | Class II | Terminated |
| D-0879-2022 | 04-27-2022 | Open Nature Cough Drops Menthol-Cough Suppressant/Oral Anesthetic Peppermint Naturally Flavored, packaged in Bags of 30 lozenges, Distributed By Lucerne Foods, Inc. P.O. Box 99, Pleasanton, CA 96566-0009, UPC 0 79893 41266 5 | Subpotent drug: Low OOS for menthol content at the three month room temperature. | Bestco LLC / 2038 bags | Class III | Terminated |
| D-0831-2022 | 04-25-2022 | Vancomycin HCl 1.5 g in 0.9% Sodium Chloride, 500 mL bags, Rx only, SCA Pharmaceuticals Windsor, CT 06095, NDC 70004-0924-44 | CGMP Deviations | SCA Pharmaceuticals / 30 bags | Class II | Terminated |
| D-0830-2022 | 04-25-2022 | Fentanyl 2mcg/ml and Bupivacaine 0.125% in 0.9% Sodium Chloride 100 mL bags, Rx only, SCA Pharmaceuticals Windsor, CT 06095, NDC 70004-0231-32 | CGMP Deviations | SCA Pharmaceuticals / 424 bags | Class II | Terminated |
| D-0829-2022 | 04-25-2022 | Norepinephrine 8mg in 0.9% Sodium Chloride 250 mL bag, Rx only, SCA Pharmaceuticals Windsor, CT 06095, NDC 70004-078-40 | CGMP Deviations | SCA Pharmaceuticals / 120 bags | Class II | Terminated |
| D-0793-2022 | 04-25-2022 | Zonisamide Capsules, USP, 100 mg, packaged in: a) 100-count bottle (NDC 68462-130-01); b) 500-count bottle (NDC 68462-130-05), Rx only, Manufactured by: Glenmark Pharmaceuticals, Inc., USA Monroe, NC 28110, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 Package NDCs: 68462-128-01; 68462-128-05; 68462-129-01; 68462-129-05; 68462-130-01; 68462-130-05 | cGMP deviations | Glenmark Pharmaceuticals Inc., USA / a) 7,044 bottles; b) 1,014 bottles | Class II | Completed |
| D-0792-2022 | 04-25-2022 | Zonisamide Capsules, USP, 50 mg, packaged in 100-count bottles, Rx only, Manufactured by: Glenmark Pharmaceuticals, Inc., USA Monroe, NC 28110, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-129-01 Package NDCs: 68462-128-01; 68462-128-05; 68462-129-01; 68462-129-05; 68462-130-01; 68462-130-05 | cGMP deviations | Glenmark Pharmaceuticals Inc., USA / 12,003 bottles | Class II | Completed |
| D-0791-2022 | 04-25-2022 | Zonisamide Capsules USP, 25 mg, packaged in 100-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals, Inc., USA Monroe, NC 28110, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-128-01 Package NDCs: 68462-128-01; 68462-128-05; 68462-129-01; 68462-129-05; 68462-130-01; 68462-130-05 | cGMP deviations | Glenmark Pharmaceuticals Inc., USA / 11,136 bottles | Class II | Completed |
| D-0873-2022 | 04-22-2022 | Accupril (Quinapril HCl Tablets) 20 mg, 90 Tablets, Rx only NDC 0071-0532-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017 | CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits. | Pfizer Inc. / 10,304 bottles | Class II | Terminated |
| D-0874-2022 | 04-22-2022 | Accupril (Quinapril HCl Tablets) 40 mg, 90 Tablets, Rx only NDC 0071-0535-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017 | CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits. | Pfizer Inc. / 8346 bottles | Class II | Terminated |
| D-0872-2022 | 04-22-2022 | Accupril (Quinapril HCl Tablets) 10 mg, 90 Tablets Rx only NDC 0071-0530-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017 | CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits. | Pfizer Inc. / 2079 bottles | Class II | Terminated |
| D-0786-2022 | 04-21-2022 | TORCO RACING FUELS HAND SANITIZER, Alcohol Antiseptic 80% Topical Solution, Hand Sanitizer Non-Sterile Solution, FDA Approved, 76590-8347-1, 3780 mL, 3.78 Liters (1 Gallon). Torco Race Fuels 2527 W. Dallas Ave. Apache Junction, AZ, 85120 | CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits. | Torco Race Fuels / 127 gallons | Class II | Terminated |
| D-0851-2022 | 04-21-2022 | Erythromycin Topical Gel USP, 2%, Net Wt 60 g tube, Rx only, Manufactured by: Teligent Pharma, Inc. Buena, NJ 08310 Distributed by: McKesson Corporation dba Sky Packaging 4971 Southridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-053-68 | CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program. | McKesson Corporation dba McKesson Drug Company / 5,640 tubes | Class II | Ongoing |
| D-0848-2022 | 04-21-2022 | Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL bottle, Rx only, Manufactured by: Teligent Pharma, Inc. Buena, NJ 08310 Distributed by: McKesson Corporation dba Sky Packaging 4071 Southridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-977-64 | CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program. | McKesson Corporation dba McKesson Drug Company / 81,757 bottles | Class II | Ongoing |
| D-0847-2022 | 04-21-2022 | Halobetasol Propionate Ointment 0.05% Net Wt., 50 gram tube, Rx Only, Manufactured by: Teligent Pharma, Inc. Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging 4071 Southridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-998-67 | CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program. | McKesson Corporation dba McKesson Drug Company / 13, 200 tubes | Class II | Ongoing |
| D-0850-2022 | 04-21-2022 | Betamethasone Dipropionate Ointment USP, 0.05%* (Augmented) (Potency expressed as betamethasone), 15 gram tube, Rx Only, Manufactured by: Teligent Pharma, Inc. Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging 4971 Southridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-996-65 | CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program. | McKesson Corporation dba McKesson Drug Company / 55,440 tubes | Class II | Ongoing |
| D-0849-2022 | 04-21-2022 | Lidocaine Prilocaine Cream USP, 2.5%/2.5% Net Wt. 30 gram tube, Rx Only, Distributed by: McKesson Corporation dba Sky Packaging 4971 Southridge Blvd., Suite 101 Memphis, TN 38141 Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, NDC 63739-054-66 | CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program. | McKesson Corporation dba McKesson Drug Company / 1176 tubes | Class II | Ongoing |
| D-0846-2022 | 04-15-2022 | Lidocaine Hydrochloride Oral Topical Solution, USP (Viscous) 2%, 100 mL per bottle, Rx only, Manufactured by Hi-Tech Pharmacal Co., Inc. Amityville, NY 11701, NDC 50383-775-04 | Failed viscosity specification - product was below specificcation | Akorn, Inc. / 66,744 bottles | Class III | Terminated |
| D-0832-2022 | 04-15-2022 | Losartan Potassium Tablets, USP, 25 mg, a) 90-count bottles (NDC # 33342-044-10), b) 1000-count bottles (NDC # 33342-044-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Package NDCs: 33342-044-10; 33342-044-12; 33342-044-07; 33342-044-44; 33342-045-10; 33342-045-12; 33342-045-07; 33342-045-44; 33342-046-10; 33342-046-12; 33342-046-07; 33342-046-44 | CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits | Macleods Pharma Usa Inc / 12,408/90 count bottles; 1670/1000 count bottles =2,786,720 tablets | Class II | Terminated |
| D-0834-2022 | 04-15-2022 | Losartan Potassium Tablets, USP, 100 mg, a) 30-count bottles (NDC # 33342-046-07), b) 90-count bottles (NDC # 33342-046-10), c) 1000-count bottles (NDC # 33342-046-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Package NDCs: 33342-044-10; 33342-044-12; 33342-044-07; 33342-044-44; 33342-045-10; 33342-045-12; 33342-045-07; 33342-045-44; 33342-046-10; 33342-046-12; 33342-046-07; 33342-046-44 | CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits | Macleods Pharma Usa Inc / 3288/30 count bottles; 23,904/90 count bottles; 3364/1000 count bottles = 5,614,000 tablets | Class II | Terminated |
| D-0833-2022 | 04-15-2022 | Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottles (NDC # 33342-045-07), b) 90-count bottles (NDC # 33342-045-10), c) 1000-count bottles (NDC # 33342-045-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Package NDCs: 33342-044-10; 33342-044-12; 33342-044-07; 33342-044-44; 33342-045-10; 33342-045-12; 33342-045-07; 33342-045-44; 33342-046-10; 33342-046-12; 33342-046-07; 33342-046-44 | CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits | Macleods Pharma Usa Inc / 3216/30 count bottles; 47,904/90 count bottles; 4269/1000 count bottles = 8,676,840 tablets | Class II | Terminated |
| D-0835-2022 | 04-15-2022 | Losartan Potassium & Hydrochlorothiazide Tablets, USP, 50 mg/12.5 mg, a) 30-count bottles (NDC# 33342-050-07), b) 90-count bottles (NDC # 33342-050-10) c) 1000-count bottles (NDC # 33342-050-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Package NDCs: 33342-050-07; 33342-050-10; 33342-050-44; 33342-050-12; 33342-051-07; 33342-051-10; 33342-051-44; 33342-051-12; 33342-052-07; 33342-052-10; 33342-052-44; 33342-052-12 | CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits | Macleods Pharma Usa Inc / N/A | Class II | Terminated |
| D-0836-2022 | 04-15-2022 | Losartan Potassium & Hydrochlorothiazide Tablets, USP, 100 mg/25 mg, a) 30-count bottles (NDC# 33342-052-07), b) 90-count bottles (NDC # 33342-052-10) c) 1000-count bottles (NDC # 33342-052-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Package NDCs: 33342-050-07; 33342-050-10; 33342-050-44; 33342-050-12; 33342-051-07; 33342-051-10; 33342-051-44; 33342-051-12; 33342-052-07; 33342-052-10; 33342-052-44; 33342-052-12 | CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits | Macleods Pharma Usa Inc / N/A | Class II | Terminated |
| D-0837-2022 | 04-15-2022 | Losartan Potassium & Hydrochlorothiazide Tablets, USP, 100 mg/12.5 mg, a) 30-count bottles (NDC# 33342-051-07), b) 90-count bottles (NDC # 33342-051-10) c) 1000-count bottles (NDC # 33342-051-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Package NDCs: 33342-050-07; 33342-050-10; 33342-050-44; 33342-050-12; 33342-051-07; 33342-051-10; 33342-051-44; 33342-051-12; 33342-052-07; 33342-052-10; 33342-052-44; 33342-052-12 | CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits | Macleods Pharma Usa Inc / N/A | Class II | Terminated |
| D-0853-2022 | 04-15-2022 | Lansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg, 10 Packs of 10 Tablets each, 100 Tablets per blister pack, Rx Only, Distributed by: Dr. Reddy's Laboratories, Inc., Princeton, NJ 08540, Made in India, NDC 43598-561-78. | Failed Dissolution Specifications | Dr. Reddy's Laboratories, Inc. / 252 Blister Packs | Class II | Terminated |
| D-1168-2022 | 04-15-2022 | Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704 | Subpotent drug | Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy / 950 mLs in 1x8 oz and 2x16 oz bottles. | Class I | Terminated |
| D-1167-2022 | 04-15-2022 | Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704, | Subpotent drug | Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy / 1,966 mLs in 12 oz; 2 oz; 16 oz and 6 oz bottles | Class I | Terminated |
| D-0794-2022 | 04-15-2022 | Lidocaine 2.5% and Prilocaine 2.5% Cream, USP, packaged in a) 5 g tubes (NDC 0591-2070-72), b) 30 g tubes (NDC 0591-2070-30), Rx Only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA | cGMP Deviations | Teva Pharmaceuticals USA Inc / 353964 units | Class II | Terminated |
| D-0878-2022 | 04-14-2022 | Phenobarbital Elixir, USP 20 mg/5 mL, 1 Pint (473 mL) bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC Tampa, FL 33624, NDC 69367-172-16 | Does Not Meet USP or OTC Monograph: Product exceeds USP specification for alcohol content | Monarch PCM, LLC / 15,730 bottles | Class III | Terminated |
| D-1051-2022 | 04-13-2022 | Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial Diluent for Glucagon, 1ml syringe, Rx only, MFG: Eli Lilly, NDC 0002-8031-01 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 13 syringes | Class II | Terminated |
| D-1014-2022 | 04-13-2022 | Epinephrine Injection, USP, Single-Dose Auto-Injectors 0.15 mg, packaged in 2 count carton, Rx only, MFG: Mylan Pharma NDC 49502-101-02 Package NDCs: 49502-102-01; 49502-102-02; 49502-101-01; 49502-101-02 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 30 packs | Class II | Terminated |
| D-1012-2022 | 04-13-2022 | EPI-Pen Jr, 2-PAK, (epinephrine injection, USP) Single-Dose Auto-Injectors 0.15 mg, packaged in 2 count carton, Rx only, MFG: Mylan Pharma, NDC 49502-501-02 Package NDCs: 49502-500-01; 49502-500-02; 49502-500-92; 49502-501-01; 49502-501-02; 49502-501-92 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 4 cartons/2 auto injectors each | Class II | Terminated |
| D-1011-2022 | 04-13-2022 | Dihydroergotamine Mesylate, Injection, USP, 1mg/mL, packaged in box of 5 x 1 mL ampules, Rx only, Manufactured for: Perrigo, Minneapolis, MN, NDC 0574-0850-10 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 1 carton | Class II | Terminated |
| D-0993-2022 | 04-13-2022 | EPI-PEN 2-PAK (epinephrine injection, USP), Single-Dose Auto-Injectors 0.3 mg, Rx only, Manufactured for: Mylan Specialty LP., NDC 49502-500-02 Package NDCs: 49502-500-01; 49502-500-02; 49502-500-92; 49502-501-01; 49502-501-02; 49502-501-92 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 5 cartons | Class II | Terminated |
| D-1040-2022 | 04-13-2022 | Ipratropium Bromide Inhalation Solution, 0.02%, 0.5 mg/2.5 mL, packaged in 25-count box (25 x 2.5 mL sterile unit-dose vials), Rx only, MFG: Nephron Pharma, NDC 0487-9801-25 Package NDCs: 0487-9801-25; 0487-9801-30; 0487-9801-60; 0487-9801-01; 0487-9801-02 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 57 pouches | Class II | Terminated |
| D-1042-2022 | 04-13-2022 | Olanzapine Orally Disintegrating Tablets, USP 10 mg, 30-count box unit dose tablets (3 blister cards each containing 10 tablets), Rx only, MFG: PAR PHARMA, NDC 49884-321-55 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 30 cartons/3 blister packs per carton | Class II | Terminated |
| D-1048-2022 | 04-13-2022 | Metronidazole Vaginal Gel USP, 0.75% with 5 applicators, Net Wt. 70 g tube, Rx only, MFG: Sandoz, NDC 0781-7077-87 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 7 tubes | Class II | Terminated |
| D-1038-2022 | 04-13-2022 | Glucagen (glucagon) for injection, packaged in a 10-count box, (10 vials each containing 1 mg per vial), Rx only, MFG: Boehringer Mannheim, NDC 0597-0053-45 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 1 carton/10 vials per carton | Class II | Terminated |
| D-1114-2022 | 04-13-2022 | Ofloxacin Otic Solution 0.3%, 5 mL bottle, Rx only, MFG: Amneal/Akyma Pharmaceuticals, NDC 69238-1615-3 Package NDCs: 69238-1616-6; 69238-1615-3 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 1 carton | Class II | Terminated |
| D-1105-2022 | 04-13-2022 | Prednisolone Acetate Ophthalmic Suspension, USP 1%, 5 mL bottle, Rx only, MFG: Sandoz Pharma, NDC 61314-637-05 Package NDCs: 61314-637-05; 61314-637-10; 61314-637-15 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 50 bottles | Class II | Terminated |
| D-1093-2022 | 04-13-2022 | Prazosin Hydrochloride Capsules, USP, 1 mg, 100-count bottle, Rx only, MFG: Mylan Pharma, NDC 0378-1101-01 Package NDCs: 0378-1101-01; 0378-1101-10; 0378-2302-01; 0378-2302-10; 0378-3205-01; 0378-3205-25 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 8 bottles/100 tablets each | Class II | Terminated |
| D-1013-2022 | 04-13-2022 | Epinephrine Injection, USP, Single-Dose Auto-Injectors 0.3 mg, packaged in 2 count carton, Rx only, MFG: Mylan Pharma, NDC 49502-102-02 Package NDCs: 49502-102-01; 49502-102-02; 49502-101-01; 49502-101-02 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 55 packs | Class II | Terminated |
| D-1027-2022 | 04-13-2022 | Aprepitant Capsule, USP, 40 mg, 1 capsule per unit dose package, Rx only, MFG: Sandoz Pharma, NDC 0781-2321-06 Package NDCs: 0781-2321-06; 0781-2321-51; 0781-2322-06; 0781-2322-68; 0781-2322-46; 0781-4063-36; 0781-2323-06; 0781-2323-68 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 29 boxes | Class II | Terminated |
| D-1041-2022 | 04-13-2022 | ClomiPHENE Citrate Tablets, USP 50 mg, 30-count bottle, Rx only, MFG: PAR Pharma, NDC 49884-701-55 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 240 cartons/3 blister packs per carton | Class II | Terminated |
| D-1083-2022 | 04-13-2022 | Transderm Scop (scopolamine) Transdermanl System, 1 mg/ 3 days, 10 (patches) transdermal Systems Multipack, Rx only, MFG: Baxter Healthcare Corp, NDC 10019-553-03 Package NDCs: 10019-553-03; 10019-553-04; 10019-553-90; 10019-553-06; 10019-008-10; 10019-008-24; 10019-008-01; 10019-008-04 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 56 cartons/10 patches each | Class II | Terminated |
| D-1118-2022 | 04-13-2022 | Cefazolin for injection USP, and Dextrose Injection, USP, 2 g, 50 mL duplex container, Rx only, MFG: B. Braun Medical Inc., NDC 0264-3105-11 Package NDCs: 0264-3103-11; 0264-3105-11; 0264-3107-11 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 39 cases | Class II | Terminated |
| D-1026-2022 | 04-13-2022 | Aparaclonidine Ophthalmic Solution 0.5% as base, 0.5%, 5 mL bottle, Rx only, MFG:Sandoz Pharma, NDC 61314-665-05 Package NDCs: 61314-665-05; 61314-665-10 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 21 bottles | Class II | Terminated |
| D-0998-2022 | 04-13-2022 | Bupivacaine HCl Injection, single dose vial, Preservative Free 0.5%, 10mL (25/ct), Rx only, Manufacturer: Auromedics Pharma LLC, NDC 55150-169-10 Package NDCs: 55150-167-10; 55150-168-30; 55150-169-10; 55150-170-30; 55150-171-10; 55150-172-30; 55150-249-50; 55150-250-50 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 224 cartons/10 vials each | Class II | Terminated |
| D-1082-2022 | 04-13-2022 | Recothrom Thrombin Topical (Recombinant), 5,000 units, packaged in a box containing a 5000-unit vial of RECOTHROM with a 5-mL prefilled diluent syringe (containing sterile 0.9% sodium chloride, USP), a sterile needle-free transfer device, a 5-mL sterile empty syringe, and a pre-printed label, Rx only, MFG: Baxter, NDC# 0338-0322-01 Package NDCs: 0338-0322-01; 0338-0324-01; 0338-0326-01; 0338-0328-01; 0338-0330-01 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 110 cartons/5000 units each | Class II | Terminated |
| D-1037-2022 | 04-13-2022 | Meclizine Hydrochloride Tablets, USP, 25 mg, 50-count cartons (5 x10 unit dose), 10 Tablets per card, 5 cards per carton, Rx only, MFG: Avkare Inc., NDC 50268-523-15 Package NDCs: 50268-522-11; 50268-522-15; 50268-523-11; 50268-523-15 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 1 box/50 blister packs per box | Class II | Terminated |
| D-1103-2022 | 04-13-2022 | Ondansetron HCL, Tab 8 mg filmcoated, 30-count bottle, Rx only, MFG: Sandoz Pharma, NDC 65862-188-30 Package NDCs: 65862-187-30; 65862-187-05; 65862-187-99; 65862-187-03; 65862-187-10; 65862-188-30; 65862-188-05; 65862-188-99; 65862-188-03; 65862-188-10; 65862-189-11 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 2 bottles/500 tablets each | Class II | Terminated |
| D-1059-2022 | 04-13-2022 | Sulfamethoxazole and Trimethoprim Tablets, USP, 800mg/160mg, 100-count unit dose box, Rx only, MFG: Major Pharma, NDC 0904-2725-61 Package NDCs: 0904-2725-61 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 32 cartons/100 blister packs per carton | Class II | Terminated |
| D-1068-2022 | 04-13-2022 | Lidocaine Patch 5%, 30-count box, Rx only, MFG: Teva Pharma USA, NDC 0591-3525-30 Package NDCs: 0591-3525-11; 0591-3525-30 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 1 carton/30 pouches | Class II | Terminated |
| D-1020-2022 | 04-13-2022 | Albuterol Sulfate Inhalation Solution 0.083%, 2.5 mg/3mL, packaged in 25 X 3mL unit-dose vials, Rx only, MFG by: Nephron Pharma, NDC 0487-9501-25 Package NDCs: 0487-9501-25; 0487-9501-03; 0487-9501-60; 0487-9501-01 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 96 pouches | Class II | Terminated |
| D-1094-2022 | 04-13-2022 | Labetalol Hydrochloride Tablets, USP, 100 mg, 100-count bottle, Rx only, MFG: Par Pharma, NDC 49884-122-01 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 1 bottle/100 tablets | Class II | Terminated |
| D-1024-2022 | 04-13-2022 | Albuterol Sulfate Inhalation Aerosol HFA 90 mcg, with Dose Indicator, 200 metered inhalations, Rx only, Distributed by: Sandoz Inc., NDC 0781-7296-85 Package NDCs: 0781-7296-85 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 1 aerosol | Class II | Terminated |
| D-1104-2022 | 04-13-2022 | Pantoprazole Sodium for Injection, 40 mg/vial, 10 single-dose vials, Rx only, MFG: Sandoz Pharma, NDC 0781-3232-95 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 1 carton/10 vials | Class II | Terminated |
| D-1009-2022 | 04-13-2022 | Ampicillin for Injection, USP, 1 g per vial, 10-count box, Rx only, Distributed by: Auromedics Pharma, NDC 55150-113-10 Package NDCs: 55150-111-10; 55150-112-10; 55150-113-10; 55150-114-20 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 10 cartons/10 vials each | Class II | Terminated |
| D-1032-2022 | 04-13-2022 | Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Distributed by: Sun Pharmaceuticals, NDC 63304-616-50 Package NDCs: 63304-614-20; 63304-614-05; 63304-614-01; 63304-614-13; 63304-615-05; 63304-615-11; 63304-615-01; 63304-616-20; 63304-616-05; 63304-616-01; 63304-616-13; 63304-616-50 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 3 bottles | Class II | Terminated |
| D-1075-2022 | 04-13-2022 | Mupirocin Ointment, USP 2%, 22 grams tube, Rx only, MFG: Teva Pharma USA, NDC 0093-1010-42, MFG: Teva Pharma USA Package NDCs: 0093-1010-42 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 5 tubes | Class II | Terminated |
| D-1117-2022 | 04-13-2022 | Cefazolin for injection USP, and Dextrose Injection, USP, 1G, 50 ML duplex container, Rx only, MFG: B. Braun Medical Inc., NDC 0264-3103-11 Package NDCs: 0264-3103-11; 0264-3105-11; 0264-3107-11 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 26 cases | Class II | Terminated |
| D-1039-2022 | 04-13-2022 | Naltrexone Hydrochloride Tablets, USP, 50 mg, 100-count bottle, Rx only, MFG: Mallinckrodt Inc., NDC 0406-1170-03 Package NDCs: 0406-1170-03; 0406-1170-01 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 4 bottles/30 tablets per bottle | Class II | Terminated |
| D-1088-2022 | 04-13-2022 | Levofloxacin Tablets, 500 mg, 100-count unit dose box, Rx only, MFG: Major Pharma, NDC 0904-6352-61 Package NDCs: 0904-6351-61; 0904-6352-61; 0904-6353-61 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 1 box/100 blisters packs per box | Class II | Terminated |
| D-0997-2022 | 04-13-2022 | Azithromycin for Injection USP Vial, 500 mg per vial, Rx only, Manufacturer: Auromedics Pharma LLC, NDC 55150-174-10 Package NDCs: 55150-174-10 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 13 carton/10 vials each | Class II | Terminated |
| D-1085-2022 | 04-13-2022 | E-Z-Gas II, Effervescent Granules, Net Weight: 4 g, 50 packets per box, MFG: Bracco Diagnostics Inc., NDC 0270-9020-01 (discontinued), NDC 10361-793-01 (current) Package NDCs: 10361-793-01; 0270-9020-01 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 16 boxes/50 pouches per box | Class II | Terminated |
| D-1115-2022 | 04-13-2022 | Diprivan (Propofol) Emulsion, 100 mg/mL, 10mL vial, Rx only, MFG: App Pharmaceutical LLC, NDC 63323-269-10 Package NDCs: 63323-269-30; 63323-269-50; 63323-269-35; 63323-269-65; 63323-269-22; 63323-269-29; 63323-269-01; 63323-269-10 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 122 cartons | Class II | Terminated |
| D-1053-2022 | 04-13-2022 | Xylocaine + Epinephrine, multi dose vial 2%, 20 mL, 25 count box, Rx only, MFG: Fresenius Kabi USA LLC, NDC 63323-483-27 Package NDCs: 63323-492-04; 63323-492-27; 63323-492-09; 63323-492-57; 63323-492-07; 63323-492-37; 63323-492-03; 63323-492-31; 63323-491-01; 63323-491-57; 63323-495-09; 63323-495-27; 63323-495-04; 63323-495-07; 63323-485-01; 63323-485-27; 63323-485-03; 63323-485-57; 63323-486-01; 63323-486-17; 63323-486-02; 63323-486-27; 63323-486-05; 63323-486-57; 63323-484-57; 63323-489-02; 63323-489-27; 63323-489-03; 63323-489-21; 63323-489-01; 63323-489-17; 63323-488-07; 63323-488-37; 63323-488-03; 63323-488-31; 63323-488-01; 63323-488-17; 63323-481-01; 63323-481-57; 63323-483-03; 63323-483-27; 63323-483-01; 63323-483-57; 63323-482-01; 63323-482-17; 63323-482-03; 63323-482-27; 63323-482-05; 63323-482-57; 63323-487-01; 63323-487-17; 63323-487-07; 63323-487-37; 63323-487-03; 63323-487-31 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 33 trays/25 vials per tray | Class II | Terminated |
| D-1034-2022 | 04-13-2022 | BSS Sterile Irrigating Solution (balanced salt solution), 500 mL bottle, Rx only, MFG: Alcon Surgical Inc, NDC 0065-0795-50 Package NDCs: 0065-0795-15; 0065-0795-30; 0065-0795-25; 0065-0795-50 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 4 bottles | Class II | Terminated |
| D-1022-2022 | 04-13-2022 | Adrenalin (epinephrine injection, USP) 30 mg/30 mL (1mg/mL), 30 mL multiple dose vial, Rx only, MFG: Par Pharma, NDC 42023-168-01 Package NDCs: 42023-159-01; 42023-159-25; 42023-168-01 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 58 cartons | Class II | Terminated |
| D-1019-2022 | 04-13-2022 | Albuterol Sulfate Inhalation Solution 0.083%, 2.5 mg/3mL, packaged in 5 x 3 mL unit-dose vials, Rx only, Manufactured by: Nephron Pharma, NDC 0487-9501-03 Package NDCs: 0487-9501-25; 0487-9501-03; 0487-9501-60; 0487-9501-01 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 23 pouches | Class II | Terminated |
| D-1096-2022 | 04-13-2022 | Depo-Medrol (methylprednisolone acetate injectable suspension, USP) 40 mg/mL, 1 mL single-dose vial, Rx only, MFG: Pfizer, NDC 0009-3073-03 Package NDCs: 0009-3073-01; 0009-3073-03; 0009-3475-01; 0009-3475-03 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 2 cartons | Class II | Terminated |
| D-1097-2022 | 04-13-2022 | Depo-Medrol (methylprednisolone acetate injectable suspension, USP) 80mg/mL, packaged in a) 1 mL single-dose vial (NDC# 0009-3475-01), b) 25-count box (NDC 0009-3475-03), Rx only, MFG: Pfizer Package NDCs: 0009-3073-01; 0009-3073-03; 0009-3475-01; 0009-3475-03 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 177 cartons | Class II | Terminated |
| D-1106-2022 | 04-13-2022 | Triamcinolone Acetonide cream, USP, 0.1% ,15 grams tube, Rx only, MFG: Sandoz Pharma, NDC 0168-0004-15 Package NDCs: 0168-0003-15; 0168-0003-80; 0168-0004-15; 0168-0004-80; 0168-0004-16; 0168-0002-15 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 30 tubes | Class II | Terminated |
| D-1025-2022 | 04-13-2022 | Amoxicillin Capsules, USP, 500 mg, 100-count bottle, Rx only, MFG: Sandoz Pharma, NDC 0781-2613-01 Package NDCs: 0781-2020-31; 0781-2020-76; 0781-2020-01; 0781-2020-05; 0781-2613-31; 0781-2613-76; 0781-2613-01; 0781-2613-05; 0781-5060-20; 0781-5060-01; 0781-5061-20; 0781-5061-01; 0781-6039-58; 0781-6039-46; 0781-6039-55; 0781-6156-52; 0781-6156-57; 0781-6156-46; 0781-6041-58; 0781-6041-46; 0781-6041-55; 0781-6157-52; 0781-6157-57; 0781-6157-46 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 12 bottles | Class II | Terminated |
| D-1045-2022 | 04-13-2022 | Hydrocortisone Ointment USP, 2.5%, NET WT 28.35 g (1 oz) tube, Rx only, MFG: Sandoz Pharma, NDC 0168-0146-30 Package NDCs: 0168-0146-16; 0168-0146-30; 0168-0080-16; 0168-0080-31 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 1 tube | Class II | Terminated |
| D-1047-2022 | 04-13-2022 | Lidocaine and Prilocaine Cream, 2.5%/2.5%, 5 gram tubes, Rx only, MFG: Sandoz Pharma, NDC 0168-0357-56 Package NDCs: 0168-0357-05; 0168-0357-55; 0168-0357-56; 0168-0357-30 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 23 tubes | Class II | Terminated |
| D-1116-2022 | 04-13-2022 | Diprivan (Propofol) Emulsion, 200 mg per 20 mL (10mg/mL), 20 mL vial, Rx only, MFG: App Pharmaceutical LLC, NDC 63323-269-29 Package NDCs: 63323-269-30; 63323-269-50; 63323-269-35; 63323-269-65; 63323-269-22; 63323-269-29; 63323-269-01; 63323-269-10 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 46 cartons | Class II | Terminated |
| D-1055-2022 | 04-13-2022 | Ibuprofen Tablets USP, 400 mg, 100-count unit dose box, Rx only, MFG: Major Pharma, NDC 0904-5853-61 Package NDCs: 0904-5853-61; 0904-5853-60; 0904-5853-40; 0904-5854-61; 0904-5854-60; 0904-5854-40; 0904-5855-61; 0904-5855-60; 0904-5855-40 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 1 carton/100 blisters per carton | Class II | Terminated |
| D-1049-2022 | 04-13-2022 | Nitrostat (Nitroglycerin Sublingual Tablets, USP) 0.4 mg/tablet, 25-count bottle, Rx only, Distributed by: Pfizer Parke-Davis, Division of Pfizer Inc., NDC 0071-0418-13 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 1 carton/4 bottles per carton/25 tablets per bottle | Class II | Terminated |
| D-1065-2022 | 04-13-2022 | Ketoconazole Cream, 2%, Net Wt 60 grams tube, Rx only, MFG: Nycomed Inc, NDC 0168-0099-60 Package NDCs: 0168-0099-15; 0168-0099-30; 0168-0099-60 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 6 tubes | Class II | Terminated |
| D-1031-2022 | 04-13-2022 | Sterile Water for Injection USP, 2000 mL, Rx only, Baxter Healthcare Corp., NDC 0338-0013-06 Package NDCs: 0338-0013-06; 0338-0013-08; 0338-0013-29 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / unknown | Class II | Terminated |
| D-1112-2022 | 04-13-2022 | Geodon for injection (ziprasidone mesylate), 20 mg/mL, 1 mL single dose vial, Rx only, MFG: Viatris, NDC 0049-3920-83 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 1 carton/10 vials | Class II | Terminated |
| D-1054-2022 | 04-13-2022 | Doxycycline Hyclate Tablets, USP, 100 mg, 50-count carton (10 tablets each blister pack x 5), Rx only, MFG: Major Pharma, NDC 0904-0430-06 Package NDCs: 0904-0430-95; 0904-0430-04; 0904-0430-06 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 108 cartons/50 blisters per carton | Class II | Terminated |
| D-1028-2022 | 04-13-2022 | Betamethasone Dipropionate Cream USP, 0.05%, 45 grams tube, Rx only, MFG: Sandoz Pharma, NDC 0168-0055-46 Package NDCs: 0168-0055-15; 0168-0055-46; 0168-0057-60 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 1 tube | Class II | Terminated |
| D-0995-2022 | 04-13-2022 | TobraDex (tobramycin and dexamethasone), Ophthalmic Ointment, 3.5 gm, Rx only, Manufacturer: Novartis, NDC 0078-0876-01 Package NDCs: 0078-0876-01 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 3 tubes | Class II | Terminated |
| D-1046-2022 | 04-13-2022 | HydrOXYzine Pamoate Capsules, USP, 50 mg, 100-count bottle, Rx only, MFG: Sandoz Pharma, NDC 0185-0615-01 Package NDCs: 0185-0674-10; 0185-0674-05; 0185-0674-01; 0185-0615-10; 0185-0615-05; 0185-0615-01; 0185-0613-10; 0185-0613-05; 0185-0613-01; 0185-0676-10; 0185-0676-05; 0185-0676-01 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 30 bottles/100 capsules per bottle | Class II | Terminated |
| D-1021-2022 | 04-13-2022 | Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution 3mL vial, packaged in a) 30-count (NDC 0487-0201-03), b) 60-count (NDC 0487-0201-60), Rx only, MFG: Nephron Pharma Package NDCs: 0487-0201-01; 0487-0201-02; 0487-0201-03; 0487-0201-60 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 56 pouches | Class III | Terminated |
| D-1102-2022 | 04-13-2022 | Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, 3.5 g tube, Rx only MFG: Sandoz, NDC 61314-631-36 Package NDCs: 61314-631-36 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 120 tubes | Class II | Terminated |
| D-1018-2022 | 04-13-2022 | Albuterol Sulfate Inhalation Solution, 0.021%, 0.63 mg/3mL, packaged in 30 x 3 mL Sterile Unit-Dose Vials, Rx only, MFG: Nephron Pharma, NDC 0487-0301-01 Package NDCs: 0487-9904-25; 0487-9904-01; 0487-9904-02; 0487-0301-01; 0487-0301-02 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 1 carton/30 pouches each | Class II | Terminated |
| D-1033-2022 | 04-13-2022 | BSS Sterile Irrigating Solution (balanced salt solution), 15 mL bottle, Rx only, MFG: Alcon Surgical Inc, NDC 0065-0795-15 Package NDCs: 0065-0795-15; 0065-0795-30; 0065-0795-25; 0065-0795-50 | cGMP deviations: Temperature abuse | Mckesson Medical-Surgical Inc. Corporate Office / 13 bottles | Class II | Terminated |
